Presentation Information

[D2-A2-02]Parallelism Best Practices for Biomarker Assay Validation and Application to LC-MS Approaches

*Barry R Jones1 (1. Crinetics Pharmaceuticals, Inc.)

Password required to view


Comment

To browse or post comments, you must log in.Log in